Methods for optimizing statistical analyses in pharmacogenomics research

Expert Review of Clinical Pharmacology

Volumn 2, Issue 5, 2009, Pages 559-570

  Turner, Stephen D ^a   Crawford, Dana C ^a   Ritchie, Marylyn D ^a  

^a VANDERBILT UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

Data analysis; Data mining; Epistasis; Genome wide association; Interaction; Methodology; Pharmacogenomics; Statistics

Indexed keywords

ANALYSIS OF VARIANCE; DATA ANALYSIS; DATA MINING; EPISTASIS; EVOLUTIONARY ALGORITHM; GENE EXPRESSION; GENOME ANALYSIS; GENOTYPE; GENOTYPE ENVIRONMENT INTERACTION; HAPLOTYPE MAP; HUMAN; LINEAR REGRESSION ANALYSIS; PHARMACOGENOMICS; PHENOTYPE; QUANTITATIVE ANALYSIS; QUANTITATIVE TRAIT LOCUS; REVIEW; SINGLE NUCLEOTIDE POLYMORPHISM; STATISTICAL ANALYSIS; TREATMENT RESPONSE;

EID: 70549105809     PISSN: 17512433     EISSN: None     Source Type: Journal    
DOI: 10.1586/ecp.09.32     Document Type: Review

References (136)

1. Roses AD. Pharmacogenetics. Hum. Mol. Genet. 10(20), 2261-2267 (2001).
2. Goldstein DB, Tate SK, Sisodiya SM. Pharmacogenetics goes genomic. Nat. Rev. Genet. 4(12), 937-947 (2003).
3. Risch N, Merikangas K. The future of genetic studies of complex human disorders. Science 273(5281), 1516-1517 (1996). (Pubitemid 26301653)
4. International hapmap consortium. The International HapMap Project. Nature 426(6968), 789-796 (2003).
5. International hapmap consortium. A second generation human haplotype map of over 3.1 million SNPs. Nature 449(7164), 851-861 (2007).
6. Itsara A, Cooper GM, Baker C et al. Population analysis of large copy number variants and hotspots of human genetic disease. Am. J. Hum. Genet. 84(2), 148-161 (2009).
7. McCarroll SA, Kuruvilla FG, Korn JM et al. Integrated detection and populationgenetic analysis of SNPs and copy number variation. Nat. Genet. 40(10), 1166-1174 (2008).
8. Jakobsson M, Scholz SW, Scheet P et al. Genotype, haplotype and copy-number variation in worldwide human populations. Nature 451(7181), 998-1003 (2008). (Pubitemid 351301742)
9. Redon R, Ishikawa S, Fitch KR et al. Global variation in copy number in the human genome. Nature 444(7118), 444-454 (2006). (Pubitemid 44809057)
10. Nelson MR, Bacanu SA, Mosteller M et al. Genomewide approaches to identify pharmacogenetic contributions to adverse drug reactions. Pharmacogenomics J. 9(1), 23-33 (2009).
11. Takeuchi F, McGinnis R, Bourgeois S et al. A genomewide association study confirms VKORC1, CYP2C9, and CYP4F2 as principal genetic determinants of warfarin dose. PLoS Genet. 5(3), e1000433 (2009).
12. Cooper GM, Johnson JA, Langaee TY et al. A genomewide scan for common genetic variants with a large influence on warfarin maintenance dose. Blood 112(4), 1022-1027 (2008).
13. Liu C, Batliwalla F, Li W et al. Genomewide association scan identifies candidate polymorphisms associated with differential response to anti-TNF treatment in rheumatoid arthritis. Mol. Med. 14(9-10), 575-581 (2008).
14. Koska MT. CEOs make the most of trustees' business acumen. Hospitals 64(11), 28-33 (1990).
15. Dumaual C, Miao X, Daly TM et al. Comprehensive assessment of metabolic enzyme and transporter genes using the Affymetrix Targeted Genotyping System. Pharmacogenomics 8(3), 293-305 (2007). (Pubitemid 46477741)
16. Caldwell MD, Awad T, Johnson JA et al. CYP4F2 genetic variant alters required warfarin dose. Blood 111(8), 4106-4112 (2008).
17. Mega JL, Close SL, Wiviott SD et al. Cytochrome p-450 polymorphisms and response to clopidogrel. N. Engl. J. Med. 360(4), 354-362 (2009).
18. Mardis ER. The impact of nextgeneration sequencing technology on genetics. Trends Genet. 24(3), 133-141 (2008).
19. Schuster SC. Next-generation sequencing transforms today's biology. Nat. Methods 5(1), 16-18 (2008).
20. Von Bubnoff A. Next-generation sequencing: the race is on. Cell 132(5), 721-723 (2008).
21. Haines JL, Pericak-Vance MA. Approaches to gene mapping in complex human diseases. John Wiley and Sons (Eds). 323-333 (1998).
22. Leon Gordis. Epidemiology. Saunders, 177-199 (2008).
23. Klein TE, Altman RB, Eriksson N et al. Estimation of the warfarin dose with clinical and pharmacogenetic data. N. Engl. J. Med. 360(8), 753-764 (2009).
24. Sills GJ. Pharmacogenetics of epilepsy: one step forward? Epilepsy Curr. 5(6), 236-238 (2005).
25. Arranz MJ, Munro J, Birkett J et al. Pharmacogenetic prediction of clozapine response. Lancet 355(9215), 1615-1616 (2000).
26. Nagasubramanian R, Innocenti F, Ratain MJ. Pharmacogenetics in cancer treatment. Annu. Rev. Med. 54, 437-452 (2003).
27. Wessels JA, van der Kooij SM, le CS et al. A clinical pharmacogenetic model to predict the efficacy of methotrexate monotherapy in recent-onset rheumatoid arthritis. Arthritis Rheum. 56(6), 1765-1775 (2007).
28. Roses AD, Saunders AM, Huang Y, Strum J, Weisgraber KH, Mahley RW. Complex disease-associated pharmacogenetics: drug efficacy, drug safety, and confirmation of a pathogenetic hypothesis (Alzheimer's disease). Pharmacogenomics J. 7(1), 10-28 (2007). (Pubitemid 46322076)
29. Siddiqui A, Kerb R, Weale ME et al. Association of multidrug resistance in epilepsy with a polymorphism in the drug-transporter gene ABCB1. N. Engl. J. Med. 348(15), 1442-1448 (2003). (Pubitemid 36407173)
30. Aulchenko YS, Ripatti S, Lindqvist I et al. Loci influencing lipid levels and coronary heart disease risk in 16 European population cohorts. Nat. Genet. 41(1), 47-55 (2009).
31. Sabatti C, Service SK, Hartikainen AL et al. Genomewide association analysis of metabolic traits in a birth cohort from a founder population. Nat. Genet. 41(1), 35-46 (2009).
32. Kathiresan S, Willer CJ, Peloso GM et al. Common variants at 30 loci contribute to polygenic dyslipidemia. Nat. Genet. 41(1), 56-65 (2009).
33. Newton-Cheh C, Johnson T, Gateva V et al. Genomewide association study identifies eight loci associated with blood pressure. Nat. Genet. (2009).
34. Cookson W, Liang L, Abecasis G, Moffatt M, Lathrop M. Mapping complex disease traits with global gene expression. Nat. Rev. Genet. 10(3), 184-194 (2009).
35. Dixon AL, Liang L, Moffatt MF et al. A genomewide association study of global gene expression. Nat. Genet. 39(10), 1202-1207 (2007). (Pubitemid 47482680)
36. Meyer-Lindenberg A, Weinberger DR. Intermediate phenotypes and genetic mechanisms of psychiatric disorders. Nat. Rev. Neurosci. 7(10), 818-827 (2006). (Pubitemid 44435264)
37. Cristea IM, Gaskell SJ, Whetton AD. Proteomics techniques and their application to hematology. Blood 103(10), 3624-3634 (2004).
38. Marchini J, Cardon LR, Phillips MS, Donnelly P. The effects of human population structure on large genetic association studies. Nat. Genet. 36(5), 512-517 (2004). (Pubitemid 38620038)
39. Need AC, Motulsky AG, Goldstein DB. Priorities and standards in pharmacogenetic research. Nat. Genet. 37(7), 671-681 (2005). • Contains an extensive list of US FDAapproved drugs withdrawn from major markets between 1990-2005 with genes implicated in variable drug response.
40. Zhu X, Tang H, Risch N. Admixture mapping and the role of population structure for localizing disease genes. Adv. Genet. 60, 547-569 (2008).
41. Britt BA, Locher WG, Kalow W. Hereditary aspects of malignant hyperthermia. Can. Anaesth. Soc. J. 16(2), 89-98 (1969).
42. Denborough MA, Forster JF, Lovell RR, Maplestone PA, Villiers JD. Anaesthetic deaths in a family. Br. J. Anaesth. 34, 395-396 (1962).
43. Laird NM, Lange C. Family-based designs in the age of large-scale gene-association studies. Nat. Rev. Genet. 7(5), 385-394 (2006).
44. Govindaraju DR, Cupples LA, Kannel WB et al. Genetics of the Framingham Heart Study population. Adv. Genet. 62, 33-65 (2008).
45. Wilk JB, Manning AK, Dupuis J et al. No evidence of major population substructure in the Framingham Heart Study. Genet. Epidemiol. 29, 234-292 (2005).
46. Ioannidis JP, Thomas G, Daly MJ. Validating, augmenting and refining genomewide association signals. Nat. Rev. Genet. 10(5), 318-329 (2009).
47. Manolio TA. Collaborative genomewide association studies of diverse diseases: programs of the NHGRI's office of population genomics. Pharmacogenomics 10(2), 235-241 (2009).
48. Lin SS, Kelsey JL. Use of race and ethnicity in epidemiologic research: concepts, methodological issues, and suggestions for research. Epidemiol. Rev. 22(2), 187-202 (2000).
49. Race ethnicity and genetics working group: the use of racial, ethnic, and ancestral categories in human genetics research. Am. J. Hum. Genet. 77(4), 519-532 (2005).
50. Seldin MF, Price AL. Application of ancestry informative markers to association studies in European Americans. PLoS Genet. 4(1), E5 (2008).
51. Yaeger R, vila-Bront A, Abdul K et al. Comparing genetic ancestry and selfdescribed race in african americans born in the United States and in Africa. Cancer Epidemiol. Biomarkers Prev. 17(6), 1329-1338 (2008).
52. Pritchard JK, Rosenberg NA. Use of unlinked genetic markers to detect population stratification in association studies. Am. J. Hum. Genet. 65(1), 220-228 (1999).
53. Reich DE, Goldstein DB. Detecting association in a case-control study while correcting for population stratification. Genet. Epidemiol. 20(1), 4-16 (2001).
54. Novembre J, Johnson T, Bryc K et al. Genes mirror geography within Europe. Nature 456(7218), 98-101 (2008).
55. Devlin B, Roeder K. Genomic control for association studies. Biometrics 55(4), 997-1004 (1999).
56. Dadd T, Weale ME, Lewis CM. A critical evaluation of genomic control methods for genetic association studies. Genet. Epidemiol. 33(4), 290-298 (2009).
57. Devlin B, Bacanu SA, Roeder K. Genomic Control to the extreme. Nat. Genet. 36(11), 1129-1130 (2004).
58. Pritchard JK, Stephens M, Donnelly P. Inference of population structure using multilocus genotype data. Genetics 155(2), 945-959 (2000). (Pubitemid 30397141)
59. Price AL, Patterson NJ, Plenge RM, Weinblatt ME, Shadick NA, Reich D. Principal components analysis corrects for stratification in genomewide association studies. Nat. Genet. 38(8), 904-909 (2006). (Pubitemid 44141658)
60. Patterson N, Price AL, Reich D. Population structure and eigenanalysis. PLoS Genet. 2(12), E190 (2006).
61. Zhang F, Wang Y, Deng HW. Comparison of population-based association study methods correcting for population stratification. PLoS ONE 3(10), e3392 (2008).
62. Maxwell SE, Delaney HD. Designing Experiments and Analyzing Data. Lawrence Erlbaum Associates (Eds) (2004).
63. Sokal RR, Rohlf FJ. Biometry. Freeman Eds, 179-450 (1995).
64. Agresti A. Categorical Data Analysis. John Wiley & Sons, San Francisco, CA, USA, 141-142 (1990).
65. Purcell S, Neale B, Todd-Brown K et al. PLINK: a tool set for whole-genome association and population-based linkage analyses. Am. J. Hum. Genet. 81(3), 559-575 (2007). (Pubitemid 47330214)
66. Mushiroda T, Ohnishi Y, Saito S et al. Association of VKORC1 and CYP2C9 polymorphisms with warfarin dose requirements in Japanese patients. J. Hum. Genet. 51(3), 249-253 (2006).
67. Maher B. Personal genomes: the case of the missing heritability. Nature 456(7218), 18-21 (2008).
68. Iles MM. What can genomewide association studies tell us about the genetics of common disease? PLoS Genet. 4(2), E33 (2008).
69. Lander ES, Schork NJ. Genetic dissection of complex traits. Science 265(5181), 2037-2048 (1994). •• Overview on using traditional linkage and association methods in the genetic analysis of complex phenotypes.
70. Moore JH, Williams SM. New strategies for identifying gene-gene interactions in hypertension. Ann. Med. 34(2), 88-95 (2002). •• Essay on statistical and biological interaction.
71. Moore JH, Williams SM. Traversing the conceptual divide between biological and statistical epistasis: systems biology and a more modern synthesis. Bioessays 27(6), 637-646 (2005).
72. Ritchie MD, Hahn LW, Roodi N et al. Multifactor-dimensionality reduction reveals high-order interactions among estrogen-metabolism genes in sporadic breast cancer. Am. J. Hum. Genet. 69(1), 138-147 (2001). (Pubitemid 32614026)
73. Wright S. The roles of mutation, inbreeding, crossbreeding, and selection in evolution. Proc. 6th Intl. Congress of Genetics 1, 356-366 (1932).
74. Gibson G. Epistasis and pleiotropy as natural properties of transcriptional regulation. Theor. Popul. Biol. 49(1), 58-89 (1996). (Pubitemid 26310419)
75. Moore JH. The ubiquitous nature of epistasis in determining susceptibility to common human diseases. Hum. Hered. 56(1-3), 73-82 (2003). • The importance of gene-gene interaction in complex traits.
76. Hirschhorn JN. Genomewide association studies - illuminating biologic pathways. N. Engl. J. Med. 360(17), 1699-1701 (2009).
77. Goldstein DB. Common genetic variation and human traits. N. Engl. J. Med. 360(17), 1696-1698 (2009).
78. Hardy J, Singleton A. Genomewide association studies and human disease. N. Engl. J. Med. 360(17), 1759-1768 (2009).
79. Kraft P, Hunter DJ. Genetic risk prediction - are we there yet? N. Engl. J. Med. 360(17), 1701-1703 (2009).
80. Shao H, Burrage LC, Sinasac DS et al. Genetic architecture of complex traits: large phenotypic effects and pervasive epistasis. Proc. Natl Acad. Sci. USA 105(50), 19910-19914 (2008).
81. Carlson CS, Eberle MA, Kruglyak L, Nickerson DA. Mapping complex disease loci in whole-genome association studies. Nature 429(6990), 446-452 (2004). (Pubitemid 38715138)
82. Baba T, Azuma S, Kashiwabara S, Toyoda Y. Sperm from mice carrying a targeted mutation of the acrosin gene can penetrate the oocyte zona pellucida and effect fertilization. J. Biol. Chem. 269(50), 31845-31849 (1994). (Pubitemid 24379557)
83. Colucci-Guyon E, Portier MM, Dunia I, Paulin D, Pournin S, Babinet C. Mice lacking vimentin develop and reproduce without an obvious phenotype. Cell 79(4), 679-694 (1994). (Pubitemid 24363811)
84. Gorry P, Lufkin T, Dierich A et al. The cellular retinoic acid binding protein I is dispensable. Proc. Natl Acad. Sci. USA 91(19), 9032-9036 (1994).
85. Gruda MC, van AJ, Rizzo CA, Durham SK, Lira S, Bravo R. Expression of FosB during mouse development: normal development of FosB knockout mice. Oncogene 12(10), 2177-2185 (1996). (Pubitemid 26168427)
86. Itohara S, Mombaerts P, Lafaille J et al. T cell receptor d gene mutant mice: independent generation of a b T cells and programmed rearrangements of g d TCR genes. Cell 72(3), 337-348 (1993).
87. Killeen N, Stuart SG, Littman DR. Development and function of T cells in mice with a disrupted CD2 gene. EMBO J. 11(12), 4329-4336 (1992).
88. Kneitz B, Herrmann T, Yonehara S, Schimpl A. Normal clonal expansion but impaired Fas-mediated cell death and anergy induction in interleukin-2-deficient mice. Eur. J. Immunol. 25(9), 2572-2577 (1995).
89. Zheng H, Jiang M, Trumbauer ME et al. Mice deficient for the amyloid precursor protein gene. Ann. NY Acad. Sci. 777, 421-426 (1996). (Pubitemid 26149224)
90. Culverhouse R, Suarez BK, Lin J, Reich T. A perspective on epistasis: limits of models displaying no main effect. Am. J. Hum. Genet. 70(2), 461-471 (2002). • Theoretical justification for the possibility of interaction with little or no main effect component.
91. Moore J, Hahn L, Ritchie M, Thornton T, and White B. Application of genetic algorithms to the discovery of complex models for simulation studies in human genetics. Proceedings of the Genetic and Evolutionary Algorithm Conference. 1150-1155 (2002).
92. Bellman R. Adaptive control processes. Princeton University Press (1961).
93. Nelson MR, Kardia SLR, Sing CF. The combinatorial partitioning method. lecture notes in computer Science 1848, 293-304 (2000).
94. Culverhouse R, Klein T, Shannon W. Detecting epistatic interactions contributing to quantitative traits. Genet. Epidemiol. 27(2), 141-152 (2004). (Pubitemid 39121794)
95. Lou XY, Chen GB, Yan L et al. A generalized combinatorial approach for detecting gene-by-gene and gene-byenvironment interactions with application to nicotine dependence. Am. J. Hum. Genet. 80(6), 1125-1137 (2007). (Pubitemid 47579348)
96. Ritchie MD, Motsinger AA. Multifactor dimensionality reduction for detecting gene-gene and gene-environment interactions in pharmacogenomics studies. Pharmacogenomics 6(8), 823-834 (2005).
97. Bishop CM. Pattern Recognition and machine learning. Springer (2006).
98. Hastie T, Tibshirani R, Friedman J. The Elements of statistical learning: data mining, inference, and prediction. Springer-Verlag (2001).
99. Good P. Permutation Tests: a practical guide to resampling methods for testing hypotheses. Springer-Verlag (2000).
100. Pattin KA, White BC, Barney N et al. A computationally efficient hypothesis testing method for epistasis analysis using multifactor dimensionality reduction. Genet. Epidemiol. 33(1), 87-94 (2008).
101. Thornton-Wells TA, Moore JH, Haines JL. Genetics, statistics and human disease: analytical retooling for complexity. Trends Genet. 20(12), 640-647 (2004). •• Overview of novel methodology for analysis of complex traits, mostly focusing on case-control designs.
102. Hung SL, Adeli H. A parallel genetic/ neural network learning algorithm for MIMD shared memory machines. IEEE Trans. Neural Netw. 5(6), 900-909 (1994).
103. Lee SW. Off-line recognition of totally unconstrained handwritten numerals using multilayer cluster neural network. IEEE Trans. Pattern Anal. Mach. Intell. 18, 648-652 (1996).
104. Likartsis A, Vlachavas I, Tsoukalas LH. A new hybrid neural-genetic methodology for improving learning: Proceedings of the Ninth IEEE International Conference on Tools with Artificial Intelligence, 32-36 (1997).
105. Yang JM, Kao CY, Horng JT. Evolving neural induction regular language using combined evolutionary algorithms: ISAI/ IFIS 1996. Mexico-USA Proceedings of Collaboration in Intelligent Systems Technologies, 162-169 (1996).
106. Zhang P, Sankai Y, Ohta M. Hybrid adaptive learning control of nonlinear system: Proceedings of the 1995 American Control Conference, 2744-2748 (1995).
107. Belew RK, McInerney J, Schraudolph NN. Evolving networks: using the genetic algorithm with connectionist learning. Computer Science & Engineering Department Technical report (1990).
108. Chen YM, O'Connell RM. Active power line conditioner with a neural network control. IEEE Transactions on Industry Applications 33, 1131-1136 (1997).
109. Topchy A, Lebedko OA. Evolving networks: using the genetic algorithm with connectionist learning. Nucl. Instrum. Methods Phys. Res. 389, 240-241 (1997).
110. Cantu-Paz E, Kamath C. Evolving neural networks to identify bent-double galaxies in the FIRST survey. Neural Netw. 16, 507-517 (2008). (Pubitemid 36379100)
111. Skinner AJ, Broughton JQ. Neural networks in computational materials science: training algorithms. Modelling and Simulation in Materials Science and Engineering 3(3), 371-390 (1995).
112. Yan W, Zhu Z, Hu R. A hybrid genetic/BP algorithm and its application for radar target classification: Proceedings of the IEEE 1997 National Aerospace and Electronics Conference 981-984 (1997).
113. Motsinger AA, Lee SL, Mellick G, Ritchie MD. GPNN: power studies and applications of a neural network method for detecting gene-gene interactions in studies of human disease. BMC Bioinformatics 7, 39 (2006). (Pubitemid 43336726)
114. Motsinger AA, Dudek SM, Hahn LW, Ritchie MD. Grammatical evolution for the optimization of neural networks for genetic association studies. Bioinformatics 32(4), 325-340 (2008).
115. Motsinger AA, Reif DM, Dudek SM, Ritchie MD. Understanding the evolutionary process of grammatical evolution neural networks for feature selection in genetic epidemiology. IEEE Symposium on Computational Intelligence and Bioinformatics and Computational Biology 1-8 (2006).
116. Motsinger AA, Reif DM, Fanelli TJ, Davis AC, Ritchie MD. Linkage disequilibrium in genetic association studies improves the performance of grammatical evolution neural networks. IEEE Symposium on Computational Intelligence and Bioinformatics and Computational Biology, 1-8 (2007).
117. Motsinger-Reif AA, Dudek SM, Hahn LW, Ritchie MD. Comparison of approaches for machine-learning optimization of neural networks for detecting gene-gene interactions in genetic epidemiology. Gen. Epidemiol. 32(4), 325-340 (2008).
118. Motsinger-Reif AA, Fanelli TJ, Davis AC, Ritchie MD. Power of grammatical evolution neural networks to detect gene-gene interactions in the presence of error. BMC. Res. Notes 1, 65 (2008).
119. Ritchie MD, White BC, Parker JS, Hahn LW, Moore JH. Optimization of neural network architecture using genetic programming improves detection and modeling of gene-gene interactions in studies of human diseases. BMC Bioinformatics 4(1), 28 (2003).
120. Ritchie MD, Coffey CSMJH. Genetic programming neural networks: a bioinformatics tool for human genetics. Lect. Notes Comput. Sci. 3102, 438-448 (2004).
121. Huang DS, Liu KH, Xu CG. A genetic programming based approach to the classification of multiclass microarray datasets. Bioinformatics Btn 644 (2008).
122. Mukhopadhyay A, Maulik U, Bandyopadhyay S. Refining genetic algorithm based fuzzy clustering through supervised learning for unsupervised cancer classification. Lect. Notes Comput. Sci. 5483, 191-202 (2009).
123. Tavares J, Mesmoudi S, Talbi E. On the efficiency of local search methods for the molecular docking problem. Lect. Notes Comput. Sci. 5483, 104-115 (2009).
124. Vullo A, Passerini A, Frasconi P, Costa F, Pollastri G. On the convergence of protein structure and dynamics. statistical learning studies of pseudo folding pathways. Lect. Notes Comput. Sci. 4973, 200-211 (2008).
125. Poli R, Langdon WB, McPhee NF. A field guide to genetic programming. Lulu enterprises (2008). •• Introduction to evolutionary computing using genetic programming. Available free in PDF format at the URL referenced in [205].
126. Witten IH, Frank E. Data mining: practical machine learning tools and techniques. Morgan Kaufmann, CA, USA (2005).
127. Bush WS, Dudek SM, Ritchie MD. Biofilter: A knowledge-integration system for the multi-locus analysis of genomewide association studies. Pac. Symp. Biocomput. 14, 368-379 (2009).
128. Moore JH, White BC. Genomewide genetic analysis using genetic programming: the critical need for expert knowledge. Genetic Programming Theory and Practice 4, 11-28 (2007).
129. White BC, Gilbert JC, Reif DM, Moore JH. A statistical comparison of grammatical evolution strategies in the domain of human genetics. Proceedings of the IEEE Congress on Evolutionary Computing, 676-682 (2005).
130. Greene CS, White BC, Moore JH. Sensible initialization using expert knowledge for genomewide analysis of epistasis using genetic programming. Proceedings of the IEEE Congress on Evolutionary Computing, 676-682 (2009) (In Press).
131. Ashburner M, Ball CA, Blake JA et al. Gene ontology: tool for the unification of biology: the gene ontology consortium. Nat. Genet. 25(1), 25-29 (2000).
132. Kanehisa M, Goto S. KEGG: kyoto encyclopedia of genes and genomes. Nucleic Acids Res. 28(1), 27-30 (2000). (Pubitemid 30047706)
133. Chanock SJ, Manolio T, Boehnke M et al. Replicating genotype-phenotype associations. Nature 447(7145), 655-660 (2007).
134. Link E, Parish S, Armitage J et al. SLCO1B1 variants and statin-induced myopathy - a genomewide study. N. Engl. J. Med. 359(8), 789-799 (2008).
135. Roden DM, Pulley JM, Basford MA et al. Development of a large-scale de-identified DNA biobank to enable personalized medicine. Clin. Pharmacol. Ther. 84(3), 362-369 (2008).
136. McCarty CA, Chapman-Stone D, Derfus T, Giampietro PF, Fost N. Community consultation and communication for a population-based DNA biobank: the Marshfield clinic personalized medicine research project. Am. J. Med. Genet. 146A(23), 3026-3033 (2008). (Pubitemid 352774642)